We are honoured to have been invited to talk on the ‘Discovery of potent cyclophilin inhibitors based on structural simplification of Sanglifehrin A’, at the SCI’s Highlights in Medicinal Chemistry III meeting in London on the 16^th October.  The talk will be presented by our Director of Discovery, Dr Vicky Steadman and will focus on the innovative science involved in designing oral macrocyclic inhibitors against a challenging protein target. 

Further details can be found here: https://www.soci.org/Events/Display-Event?EventCode=FCHEM531